BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30235467)

  • 1. [Integrating cervical cancer screening and HPV vaccination: a pilot experience in the Apulia region of Italy].
    Fortunato F; Cappelli MG; Prato R; Martinelli D;
    Ig Sanita Pubbl; 2018; 74(3):265-277. PubMed ID: 30235467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and cost of cervical cancer care and prevention in Apulia (Italy), 2007/2016.
    Bianchi FP; Gallone MS; Fortunato F; Boccalini S; Martinelli D; Prato R; Tafuri S
    Ann Ig; 2018; 30(6):490-501. PubMed ID: 30614498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15-16 years in Italy.
    Visioli CB; Giorgi Rossi P; Armaroli P; Iossa A; Rizzolo R; Bonelli LA; Venturino E; Carozzi FM; Bisanzi S; De Marco L; Giordano L; Camussi E; Del Mistro A; Zappa M
    J Med Screen; 2023 Sep; 30(3):142-149. PubMed ID: 36999190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.
    Hestbech MS; Lynge E; Kragstrup J; Siersma V; Vazquez-Prada Baillet M; Brodersen J
    BMJ Open; 2015 Aug; 5(8):e007921. PubMed ID: 26275901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Cancer Screening and Prevention in 78 Sexually Transmitted Disease Clinics-United States, 2014-2015.
    McGinnis E; Meyerson BE; Meites E; Saraiya M; Griesse R; Snoek E; Haderxhanaj L; Markowitz LE; Smith W
    Sex Transm Dis; 2017 Oct; 44(10):637-641. PubMed ID: 28876317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
    Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
    Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
    Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer prevention: An Italian scenario between organised screening and human papillomaviruses vaccination.
    Cappelli MG; Fortunato F; Tafuri S; Boccalini S; Bonanni P; Prato R; Martinelli D
    Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12905. PubMed ID: 30178893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-FASTER: broadening the scope for prevention of HPV-related cancer.
    Bosch FX; Robles C; Díaz M; Arbyn M; Baussano I; Clavel C; Ronco G; Dillner J; Lehtinen M; Petry KU; Poljak M; Kjaer SK; Meijer CJ; Garland SM; Salmerón J; Castellsagué X; Bruni L; de Sanjosé S; Cuzick J
    Nat Rev Clin Oncol; 2016 Feb; 13(2):119-32. PubMed ID: 26323382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccination and cervical cancer screening.
    Bewley S
    Lancet; 2022 May; 399(10339):1939. PubMed ID: 35598621
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccination and cervical cancer screening.
    Kamamoto S; Murayama A; Hamaki T; Kusumi E; Kami M
    Lancet; 2022 May; 399(10339):1939-1940. PubMed ID: 35598620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women.
    Levi M; Bonanni P; Burroni E; Bechini A; Boccalini S; Sani C; Bonaiuti R; Indiani L; Azzari C; Lippi F; Carozzi F;
    Hum Vaccin Immunother; 2013 Jul; 9(7):1407-12. PubMed ID: 23571176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV vaccination and cervical cancer screening - Authors' reply.
    Sasieni P; Castanon A
    Lancet; 2022 May; 399(10339):1940. PubMed ID: 35598622
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
    Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
    Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.